p-glycoprotein express malign lymphoma revers clinic drug resist chemotherapi high-dos verapamil p-glycoprotein transmembran protein efflux pump cell multidrug resist laboratori system human tumor vitro clinic drug resist immunohistochem method monoclon antibodi express p-glycoprotein lymphoma patient untreat lymphoma patient drug-resist patient detect level p-glycoprotein prior report verapamil drug-resist cancer cell competit inhibit p-glycoprotein efficaci verapamil chemosensit patient drug-refractori diseas patient month doxorubicin-vincristine-contain drug regimen patient cyclophosphamid continu infus doxorubicin vincristin oral dexamethason cvad cvad continu infus verapamil dose overal patient treatment complet remiss cr median durat respons day median surviv day dose-limit toxic verapamil infus temporari cardiac dysfunct hypotens congest heart failur cardiac arrhythmia p-glycoprotein untreat lymphoma drug-resist diseas chemotherapi cvad toler dose verapamil result high respons rate patient clinic drug resist 